The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

John M. Bennett · Annals of Internal Medicine · 1985 · 2.9K citations

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Robert J. Mayer, Roger B. Davis, Charles A. Schiffer et al. · New England Journal of Medicine · 1994 · 1.4K citations · Full text

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · Journal of Clinical Oncology · 1998 · 288 citations · Full text

Acute myelogenous leukemia: recent advances in therapy

Richard E. Champlin, Gale Rp · Blood · 1987 · 216 citations · Full text

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · PubMed · 1997 · 206 citations